Abl Kinase, Active, Recombinant, Human, His-Tag (ABL, Tyrosine-protein Kinase ABL1, Abelson Murine Leukemia Viral Oncogene Homolog 1, c-Abl, Proto-oncogene c-Abl, p150, ABL1, JTK7)
Catalog No : USB-137251
627.60€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Abl Kinase, Active, Recombinant, Human, His-Tag (ABL, Tyrosine-protein Kinase ABL1, Abelson Murine Leukemia Viral Oncogene Homolog 1, c-Abl, Proto-oncogene c-Abl, p150, ABL1, JTK7) | ||
|---|---|---|---|
| Catalog No | USB-137251 | ||
| Supplier’s Catalog No | 137251 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Sf9 insect cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 33 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | Purified (~75%) | ||
| Form | Supplied as a liquid in 25mM Tris-HCl, pH 8.0, 100mM sodium chloride, 0.05% Tween 20, 20% glycerol, 3mM DTT. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | Purified (~75%) | ||
| Description | The c-ABL proto-oncogene encodes a protein tyrosine kinase that is located in the cytoplasm and nucleus. In chronic myelogenous leukemia and in a subset of acute lymphoblastic leukemias, the c-ABL proto- oncogene undergoes a chromosomal translocation producing a novel rearranged chromosome (the Philadelphia chromosome) as a result of the fustion of c-ABL sequences from chromosome 9 to the Bcr gene on chromosome 22. The molecular consequence of this translocation is the generation of a chimeric Bcr/ABL mRNA encoding activated ABL protein tyrosine kinase. Source: Recombinant corresponding to aa248-531 from human Abelson murine leukemia viral oncogene homolog 1, fused to His-tag at N-terminal, expressed in a Baculovirus-infected Sf9 cell expression system. Molecular Weight: ~33kD Applications: Suitable for use in the study of enzyme kinetics, screening inhibitors, and selectivity profiling. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Specific Activity: ~288pmol/min/ug Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70°C. Aliquots are stable for 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. | ||
Product Details
© 2020 Imugex All Rights Reserved